Twelve-Month Data Presented for iVascular's Angiolite DES


July 3, 2018—Twelve-month results from ANGIOLITE trial were presented by J. Moreu Burgos, MD, at EuroPCR 2018, which was held May 21–25 in Paris, France. The randomized, prospective, multicenter, controlled trial enrolled 223 patients with the objective of demonstrating the noninferiority of iVascular's Angiolite drug-eluting stent (DES) versus Abbott Vascular's Xience DES.

Dr. Moreu Burgos commented in the company's press release, “Angiolite DES demonstrates a favorable early healing profile, long-term efficacy, and optimized deliverability."

According to iVascular, both primary and secondary endpoints were met with statistical significance. At 6 months, late lumen loss was 0.04 mm, target lesion failure (composite endpoint) was 5.4%, binary artery restenosis (intrastent) was 0.7%, and definite thrombosis was 0.7%. At 12 months, the rate of major adverse cardiac events was 6.4%.

Optical coherence tomography results at 6 months confirmed optimal struts coverage (90.8%) with only 64.3-µm neointimal thickness and very low malapposition (1.3%), despite a high ratio of myocardial infarction patients, stated iVascular.

The company added that the data confirm the safety and long-term efficacy of the Angiolite DES. The 24-month results of the ANGIOLITE trial are expected to be presented at EuroPCR 2019.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.